GALECTIN THERAPEUTICS INC — Director's Dealing 2013

Mar 14, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2013-03-12

Reporting Person: Prelack Steven (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-12	Common Stock	M	1167	$2.28	Acquired	3567	Direct
2013-03-12	Common Stock	F	631	$4.22	Disposed	2936	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-12	Employee Stock Option (right to buy)	$2.28	M	1167	Disposed	2013-03-13	Common Stock (1167)	Direct

Footnotes

F1: The Company effected a 1-for-6 reverse stock split in March 2012, resulting in a corresponding reduction in the number of shares of common stock owned by the reporting person.

F2: This option was previously reported as covering 7,000 shares at an exercise price of $0.38 per share, but was adjusted to reflect the 1-for-6 reverse stock split that occurred in March 2012.